<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01263561</url>
  </required_header>
  <id_info>
    <org_study_id>07-0888-A</org_study_id>
    <nct_id>NCT01263561</nct_id>
  </id_info>
  <brief_title>Prospective Randomized Study Comparing Ex-PRESS to Trabeculectomy</brief_title>
  <official_title>Prospective Randomized Study Comparing Ex-PRESS to Trabeculectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective randomized study comparing guarded Ex-PRESS to trabeculectomy. Primary outcome:
      IOP and success (complete success defined as IOP between 5-18 mmHg and 20% reduction from
      baseline without medication or additional glaucoma surgery and qualified success defined as
      IOP between 5-18 mmHg and 20% reduction from baseline with or without glaucoma medication but
      no additional glaucoma surgery). Secondary outcomes: number of glaucoma medications, visual
      acuity, number of complications, corneal pachymetry and corneal endothelial cell counts.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Complications will be evaluated for the intra-operative, early post-operative (up until 1
      month) and late post-operative (from 1 month to 1 year) periods. In addition complications
      will be evaluated as severe (defined as a permanent reduction in vision or complications
      requiring a surgical intervention) and not severe (complications which resolve with
      conservative management). As an individual subject may have more than one complication, the
      number of complications will be compared between the two surgical groups.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intraocular Pressure</measure>
    <time_frame>1 year post surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Success Rate (IOP Between 5-18 mmHg and 20% Reduction From Baseline) Without Glaucoma Medication</measure>
    <time_frame>1 year post surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>1 year post surgery</time_frame>
    <description>Complications will be evaluated for the intra-operative, early post-operative (up until 1 month) and late post-operative (from 1 month to 1 year) periods. In addition complications will be evaluated as severe (defined as a permanent reduction in vision or complications requiring a surgical intervention) and not severe (complications which resolve with conservative management). As an individual subject may have more than one complication, the number of complications will be compared between the two surgical groups.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">64</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>trabeculectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>trabeculectomy filtering surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ExPRESS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ExPRESS miniature glaucoma drainage device</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ExPRESS shunt</intervention_name>
    <description>ExPRESS miniature glaucoma drainage device</description>
    <arm_group_label>ExPRESS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>trabeculectomy</intervention_name>
    <description>trabeculectomy filtering surgery</description>
    <arm_group_label>trabeculectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18 to 85

          -  open-angle glaucoma uncontrolled medically

          -  intraocular pressure â‰¥ 18 mmHg

          -  trabeculectomy as the planned surgical procedure

        Exclusion Criteria:

          -  any previous ocular incisional surgery with the exception of previous clear

          -  cornea cataract surgery

          -  uveitis

          -  vitreous present in anterior chamber

          -  patient unwilling or unable to accept randomization or to give consent or to attend
             the follow up visits
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Graham E Trope, Professor</last_name>
    <role>Study Director</role>
    <affiliation>University of Toronto</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yvonne M Buys, Professor</last_name>
    <role>Study Director</role>
    <affiliation>University of Toronto</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Ophthalmology and Vision Sciences Toronto Westarn Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T 2S8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 14, 2010</study_first_submitted>
  <study_first_submitted_qc>December 17, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 20, 2010</study_first_posted>
  <results_first_submitted>December 1, 2014</results_first_submitted>
  <results_first_submitted_qc>December 7, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 9, 2014</results_first_posted>
  <last_update_submitted>December 7, 2014</last_update_submitted>
  <last_update_submitted_qc>December 7, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 9, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Toronto</investigator_affiliation>
    <investigator_full_name>Yvonne Buys</investigator_full_name>
    <investigator_title>MD, FRCSC; Professor</investigator_title>
  </responsible_party>
  <keyword>glaucoma</keyword>
  <keyword>filtration surgery</keyword>
  <keyword>trabeculectomy</keyword>
  <keyword>ExPRESS shunt</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Trabeculectomy</title>
          <description>trabeculectomy filtering surgery
trabeculectomy: trabeculectomy filtering surgery</description>
        </group>
        <group group_id="P2">
          <title>ExPRESS</title>
          <description>ExPRESS miniature glaucoma drainage device
ExPRESS shunt: ExPRESS miniature glaucoma drainage device</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
                <participants group_id="P2" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="31"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Trabeculectomy</title>
          <description>trabeculectomy filtering surgery
trabeculectomy: trabeculectomy filtering surgery</description>
        </group>
        <group group_id="B2">
          <title>ExPRESS</title>
          <description>ExPRESS miniature glaucoma drainage device
ExPRESS shunt: ExPRESS miniature glaucoma drainage device</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="31"/>
            <count group_id="B2" value="33"/>
            <count group_id="B3" value="64"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.9" spread="11.5"/>
                    <measurement group_id="B2" value="62" spread="13.9"/>
                    <measurement group_id="B3" value="63.9" spread="12.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>intraocular pressure</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22" spread="6.8"/>
                    <measurement group_id="B2" value="22.6" spread="10.2"/>
                    <measurement group_id="B3" value="22.3" spread="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>glaucoma medications</title>
          <units>number of medications</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.4" spread="1.3"/>
                    <measurement group_id="B2" value="3.5" spread=".9"/>
                    <measurement group_id="B3" value="3.5" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>visual acuity</title>
          <units>logMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value=".48" spread=".6"/>
                    <measurement group_id="B2" value=".42" spread=".6"/>
                    <measurement group_id="B3" value=".44" spread=".56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Intraocular Pressure</title>
        <time_frame>1 year post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Trabeculectomy</title>
            <description>trabeculectomy filtering surgery
trabeculectomy: trabeculectomy filtering surgery</description>
          </group>
          <group group_id="O2">
            <title>ExPRESS</title>
            <description>ExPRESS miniature glaucoma drainage device
ExPRESS shunt: ExPRESS miniature glaucoma drainage device</description>
          </group>
        </group_list>
        <measure>
          <title>Intraocular Pressure</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.7" spread="3.5"/>
                    <measurement group_id="O2" value="11.2" spread="4.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A sample size calculation determined that 52 eyes were required to detect a 2.0 mmHg IOP difference with a power of 80%.</non_inferiority_desc>
            <p_value>.85</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Success Rate (IOP Between 5-18 mmHg and 20% Reduction From Baseline) Without Glaucoma Medication</title>
        <time_frame>1 year post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Trabeculectomy</title>
            <description>trabeculectomy filtering surgery
trabeculectomy: trabeculectomy filtering surgery</description>
          </group>
          <group group_id="O2">
            <title>ExPRESS</title>
            <description>ExPRESS miniature glaucoma drainage device
ExPRESS shunt: ExPRESS miniature glaucoma drainage device</description>
          </group>
        </group_list>
        <measure>
          <title>Success Rate (IOP Between 5-18 mmHg and 20% Reduction From Baseline) Without Glaucoma Medication</title>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57"/>
                    <measurement group_id="O2" value="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Power calculation only for main outcome measure of IOP.</non_inferiority_desc>
            <p_value>.24</p_value>
            <method>Kaplan Meier</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Complications</title>
        <description>Complications will be evaluated for the intra-operative, early post-operative (up until 1 month) and late post-operative (from 1 month to 1 year) periods. In addition complications will be evaluated as severe (defined as a permanent reduction in vision or complications requiring a surgical intervention) and not severe (complications which resolve with conservative management). As an individual subject may have more than one complication, the number of complications will be compared between the two surgical groups.</description>
        <time_frame>1 year post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Trabeculectomy</title>
            <description>trabeculectomy filtering surgery
trabeculectomy: trabeculectomy filtering surgery</description>
          </group>
          <group group_id="O2">
            <title>ExPRESS</title>
            <description>ExPRESS miniature glaucoma drainage device
ExPRESS shunt: ExPRESS miniature glaucoma drainage device</description>
          </group>
        </group_list>
        <measure>
          <title>Complications</title>
          <description>Complications will be evaluated for the intra-operative, early post-operative (up until 1 month) and late post-operative (from 1 month to 1 year) periods. In addition complications will be evaluated as severe (defined as a permanent reduction in vision or complications requiring a surgical intervention) and not severe (complications which resolve with conservative management). As an individual subject may have more than one complication, the number of complications will be compared between the two surgical groups.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Early transient hypotony</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Late transient hypotony</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>encapsulated bleb</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>choroidal effusion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>early bleb leak</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>membrane over ExPRESS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ExPRESS eroding through sclera</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total # of subjects with a complication</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Power calculation only performed for main outcome measure of IOP.</non_inferiority_desc>
            <p_value>0.80</p_value>
            <p_value_desc>Above p is for number of subjects with any complication. P values above 0.05 are considered statistically insignificant in this study.</p_value_desc>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Trabeculectomy</title>
          <description>trabeculectomy filtering surgery
trabeculectomy: trabeculectomy filtering surgery</description>
        </group>
        <group group_id="E2">
          <title>ExPRESS</title>
          <description>ExPRESS miniature glaucoma drainage device
ExPRESS shunt: ExPRESS miniature glaucoma drainage device</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Yvonne Buys</name_or_title>
      <organization>Department of Ophthalmology and Vision Sciences, University of Toronto</organization>
      <phone>416-603-5682</phone>
      <email>y.buys@utoronto.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

